Generated by GPT-5-mini| Lewy Body Dementia Association | |
|---|---|
| Name | Lewy Body Dementia Association |
| Type | Nonprofit organization |
| Founded | 2003 |
| Headquarters | United States |
| Focus | Lewy body dementia support, research, education |
Lewy Body Dementia Association The Lewy Body Dementia Association is a nonprofit organization dedicated to supporting individuals affected by Lewy body dementia and funding research into Lewy body disease. It works with clinical centers, academic institutions, patient advocacy groups, and international organizations to coordinate care, promote clinical trials, and raise public awareness. The association engages families, caregivers, neurologists, and policymakers through conferences, publications, and multimedia resources.
The association was established in 2003 following meetings among clinicians from Mayo Clinic, Johns Hopkins Hospital, Massachusetts General Hospital, and patient advocates connected to Alzheimer's Association, Parkinson's Foundation, and AARP affiliates. Early collaborations included researchers from Columbia University, University of California, San Francisco, and King's College London as well as patient groups linked to National Institutes of Health, National Institute on Aging, and private foundations such as Michael J. Fox Foundation. Key milestones involved partnerships with academic centers like University of Pennsylvania, Harvard Medical School, and University College London to refine diagnostic criteria and clinical guidelines.
The association's mission emphasizes support for patients and caregivers, education for clinicians, and promotion of research, aligning with initiatives at World Health Organization, Centers for Disease Control and Prevention, European Commission, and philanthropic organizations including Gates Foundation and Robert Wood Johnson Foundation. Activities include convening scientific symposia with specialists from Stanford University, Yale University, University of Oxford, and Karolinska Institutet and producing resources used by staff at Veterans Health Administration, National Health Service, and specialty clinics in collaboration with societies such as American Academy of Neurology and Movement Disorder Society.
Programs include helplines staffed by trained volunteers, caregiver support groups modeled after services from Alzheimer's Association, Family Caregiver Alliance, and National Alliance on Mental Illness, and a resource library with input from authors associated with Oxford University Press, Springer Nature, and Cambridge University Press. Clinical referral programs link patients to centers like Cleveland Clinic, Mount Sinai Health System, University of Toronto, and Vanderbilt University Medical Center while educational webinars feature speakers from Columbia University Irving Medical Center, University of Chicago, and Emory University.
The association funds and promotes research grants with investigators at University of Pittsburgh, Northwestern University, Duke University School of Medicine, and University of Michigan and collaborates on multicenter studies with Alzheimer's Disease Research Centers and consortia tied to National Institutes of Health programs. Advocacy efforts have engaged lawmakers and agencies including United States Congress, U.S. Department of Health and Human Services, European Parliament, and regulators like Food and Drug Administration to support clinical trial networks, biomarker development, and drug approval pathways used by companies such as Biogen, Roche, and Eli Lilly and Company.
Public campaigns have drawn on storytelling formats similar to initiatives by BBC, NBCUniversal, The New York Times, and The Washington Post to spotlight patient narratives and clinical breakthroughs originating at institutions like Scripps Research, Gladstone Institutes, and Mount Sinai. Educational outreach includes conferences and materials adapted by medical schools such as Perelman School of Medicine, Johns Hopkins School of Medicine, and Icahn School of Medicine at Mount Sinai and is featured in continuing education programs run by American Medical Association and Association of American Medical Colleges.
The organization is governed by a board of directors including clinicians, researchers, and advocates with affiliations to Johns Hopkins Medicine, Mayo Clinic, University of California, Los Angeles, and Columbia University. Funding sources comprise individual donations, grants from entities like National Institute on Aging, corporate sponsorships from pharmaceutical companies including Pfizer and Novartis, and philanthropic gifts from families and foundations such as Kresge Foundation and regional community foundations. Financial oversight follows practices recommended by Charity Navigator and GuideStar standards.
Strategic partnerships include alliances with Alzheimer's Association, Parkinson's Foundation, Dementia Society of America, academic centers like UCL Queen Square Institute of Neurology, and international networks including World Dementia Council. Impact is measured through increased clinical trial enrollment at centers such as Massachusetts General Hospital and University of California, San Diego, publication of consensus diagnostic criteria applied by researchers at National Institutes of Health and citation in journals like The Lancet, Neurology (journal), and JAMA. The association's work has influenced policy discussions at U.S. Department of Labor, improved caregiver resources mirrored by HelpAge International, and informed clinical practice guidelines adopted by American Academy of Neurology and international neurological societies.